ACRYLATE-FREE COSMETIC EMULSION

Abstract

Acrylate-free cosmetic O/W emulsion containing: at least one substance selected from the group sodium stearoyl glutamate, alkali metal alkyl sulphates, and alkali metal alkyl phosphates, wherein the alkyl group in each case has 16 to 18 carbon atoms; hydroxypropyl starch phosphate; and glycerol monostearate and/or sorbitan monostearate.

Claims

1.-15. (canceled)

16. A cosmetic emulsion, wherein the emulsion is an acrylate-free O/W emulsion which comprises (a) at least one substance selected from sodium stearoyl glutamate, alkali metal alkyl sulfates and alkali metal alkyl phosphates, wherein the alkyl group has in each case 16 to 18 carbon atoms, (b) hydroxypropyl starch phosphate, and (c) glycerol monostearate and/or sorbitan monostearate.

17. The cosmetic emulsion of claim 16, wherein (a) comprises sodium stearoyl glutamate.

18. The cosmetic emulsion of claim 16, wherein (a) comprises one or more of sodium cetyl sulfate, sodium stearyl sulfate, and sodium cetearyl sulfate.

19. The cosmetic emulsion of claim 16, wherein (a) comprises one or more alkali metal alkyl phosphates.

20. The cosmetic emulsion of claim 19, wherein (a) comprises potassium cetyl phosphate.

21. The cosmetic emulsion of claim 16, wherein the emulsion comprises from 0.01% to 5.0% by weight of (a), based on a total weight of the emulsion.

22. The cosmetic emulsion of claim 21, wherein the emulsion comprises from 0.05% to 2.0% by weight of (a).

23. The cosmetic emulsion of claim 16, wherein the emulsion comprises from 0.1% to 10% by weight of (b), based on a total weight of the emulsion.

24. The cosmetic emulsion of claim 23, wherein the emulsion comprises from 0.2% to 5.0% by weight of (b).

25. The cosmetic emulsion of claim 16, wherein (b) comprises an esterification product based on corn starch.

26. The cosmetic emulsion of claim 16, wherein the emulsion comprises from 0.1% to 5.0% by weight of (c), based on a total weight of the emulsion.

27. The cosmetic emulsion of claim 26, wherein the emulsion comprises from 0.2% to 3.0% by weight of (c).

28. The cosmetic emulsion of claim 16, wherein a proportion of an oil phase is from more than 3% to 30% by weight, based on a total weight of the emulsion.

29. The cosmetic emulsion of claim 16, wherein the emulsion further comprises one or more fatty alcohols having from 14 to 22 carbon atoms.

30. The cosmetic emulsion of claim 16, wherein the emulsion further comprises one or more of waxes and oils based on hydrocarbons; saturated, unsaturated or hardened triglycerides; dialkyl ethers having from 12 to 24 carbon atoms; esters of monohydric alcohols and monocarboxylic acids having at least 10 carbon atoms.

31. The cosmetic emulsion of claim 16, wherein the emulsion is free of silicone oils.

32. The cosmetic emulsion of claim 16, wherein the emulsion comprises a total of from 0% to 2% by weight of surfactants and/or emulsifiers, based on a total weight of the emulsion.

33. The cosmetic emulsion of claim 16, wherein the emulsion comprises from 60% to 95% by weight of water, based on a total weight of the emulsion.

34. The cosmetic emulsion of claim 33, wherein the emulsion comprises from 70% to 90% by weight of water.

35. A method of preventing phase separation in an acrylate-free O/W emulsion, wherein the method comprises including in the acrylate-free O/W emulsion (a) at least one substance selected from sodium stearoyl glutamate, alkali metal alkyl sulfates and alkali metal alkyl phosphates, wherein the alkyl group has in each case 16 to 18 carbon atoms, (b) hydroxypropyl starch phosphate, and (c) glycerol monostearate and/or sorbitan monostearate.

Description

[0054] A preferred embodiment of the invention is characterized in that the O/W emulsion, based on the total weight of the emulsion, contains [0055] a) 0.1% by weight to 1.0% by weight at least one substance selected from the group sodium stearoyl glutamate, alkali metal alkyl sulfates and alkali metal alkyl phosphates, wherein the alkyl group has in each case 16 to 18 carbon atoms, [0056] b) 0.5% by weight to 3.0% by weight hydroxypropyl starch phosphate, and [0057] c) 0.5% by weight to 2.5% by weight glycerol monostearate and/or sorbitan monostearate,
and the proportion of the oil phase of the emulsion is from more than 5% by weight to 25% by weight.

[0058] A further preferred embodiment of the invention is characterized in that the O/W emulsion, based on the total weight of the emulsion, contains [0059] a) 0.1% by weight to 1.0% by weight at least one substance selected from the group sodium stearoyl glutamate, alkali metal alkyl sulfates and alkali metal alkyl phosphates, wherein the alkyl group has in each case 16 to 18 carbon atoms, [0060] b) 0.5% by weight to 3.0% by weight hydroxypropyl starch phosphate, and [0061] c) 0.5% by weight to 2.5% by weight glycerol monostearate,
and the proportion of the oil phase of the emulsion is from more than 5% by weight to 25% by weight.

[0062] A preferred embodiment of the invention is characterized in that the O/W emulsion, based on the total weight of the emulsion, contains [0063] a) 0.1% by weight to 1.0% by weight at least one substance selected from the group sodium stearoyl glutamate, alkali metal alkyl sulfates and alkali metal alkyl phosphates, wherein the alkyl group has in each case 16 to 18 carbon atoms, [0064] b) 0.5% by weight to 3.0% by weight hydroxypropyl starch phosphate, and [0065] c) 0.5% by weight to 2.5% by weight sorbitan monostearate,
and the proportion of the oil phase of the emulsion is from more than 5% by weight to 25% by weight.

[0066] A preferred embodiment of the invention is characterized in that the O/W emulsion, based on the total weight of the emulsion, contains [0067] a) 0.1% by weight to 1.0% by weight sodium stearoyl glutamate, [0068] b) 0.5% by weight to 3.0% by weight hydroxypropyl starch phosphate, and [0069] c) 0.5% by weight to 2.5% by weight glycerol monostearate and/or sorbitan monostearate,
and the proportion of the oil phase of the emulsion is from more than 5% by weight to 25% by weight.

[0070] A further preferred embodiment of the invention is characterized in that the O/W emulsion, based on the total weight of the emulsion, contains [0071] a) 0.1% by weight to 1.0% by weight sodium stearoyl glutamate, [0072] b) 0.5% by weight to 3.0% by weight hydroxypropyl starch phosphate, and [0073] c) 0.5% by weight to 2.5% by weight glycerol monostearate,
and the proportion of the oil phase of the emulsion is from more than 5% by weight to 25% by weight.

[0074] A preferred embodiment of the invention is characterized in that the O/W emulsion, based on the total weight of the emulsion, contains [0075] a) 0.1% by weight to 1.0% by weight sodium stearoyl glutamate, [0076] b) 0.5% by weight to 3.0% by weight hydroxypropyl starch phosphate, and [0077] c) 0.5% by weight to 2.5% by weight sorbitan monostearate,
and the proportion of the oil phase of the emulsion is from more than 5% by weight to 25% by weight.

[0078] A preferred embodiment of the invention is characterized in that the O/W emulsion, based on the total weight of the emulsion, contains [0079] a) 0.1% by weight to 1.0% by weight sodium cetyl sulfate, sodium stearyl sulfate and/or sodium cetearyl sulfate, [0080] b) 0.5% by weight to 3.0% by weight hydroxypropyl starch phosphate, and [0081] c) 0.5% by weight to 2.5% by weight glycerol monostearate and/or sorbitan monostearate,
and the proportion of the oil phase of the emulsion is from more than 5% by weight to 25% by weight.

[0082] A further preferred embodiment of the invention is characterized in that the O/W emulsion, based on the total weight of the emulsion, contains [0083] a) 0.1% by weight to 1.0% by weight sodium cetyl sulfate, sodium stearyl sulfate and/or sodium cetearyl sulfate, [0084] b) 0.5% by weight to 3.0% by weight hydroxypropyl starch phosphate, and [0085] c) 0.5% by weight to 2.5% by weight glycerol monostearate,
and the proportion of the oil phase of the emulsion is from more than 5% by weight to 25% by weight.

[0086] A preferred embodiment of the invention is characterized in that the O/W emulsion, based on the total weight of the emulsion, contains [0087] a) 0.1% by weight to 1.0% by weight sodium cetyl sulfate, sodium stearyl sulfate and/or sodium cetearyl sulfate, [0088] b) 0.5% by weight to 3.0% by weight hydroxypropyl starch phosphate, and [0089] c) 0.5% by weight to 2.5% by weight sorbitan monostearate,
and the proportion of the oil phase of the emulsion is from more than 5% by weight to 25% by weight.

[0090] A preferred embodiment of the invention is characterized in that the O/W emulsion, based on the total weight of the emulsion, contains [0091] a) 0.1% by weight to 1.0% by weight at least one substance selected from the group of the alkali metal alkyl phosphates, characterized in that the alkyl group has in each case 16 to 18 carbon atoms, wherein the substance is particularly preferably potassium cetyl phosphate, [0092] b) 0.5% by weight to 3.0% by weight hydroxypropyl starch phosphate, and [0093] c) 0.5% by weight to 2.5% by weight glycerol monostearate and/or sorbitan monostearate,
and the proportion of the oil phase of the emulsion is from more than 5% by weight to 25% by weight.

[0094] A further preferred embodiment of the invention is characterized in that the O/W emulsion, based on the total weight of the emulsion, contains [0095] a) 0.1% by weight to 1.0% by weight at least one substance selected from the group of the alkali metal alkyl phosphates, characterized in that the alkyl group has in each case 16 to 18 carbon atoms, wherein the substance is particularly preferably potassium cetyl phosphate, [0096] b) 0.5% by weight to 3.0% by weight hydroxypropyl starch phosphate, and [0097] c) 0.5% by weight to 2.5% by weight glycerol monostearate,
and the proportion of the oil phase of the emulsion is from more than 5% by weight to 25% by weight.

[0098] A preferred embodiment of the invention is characterized in that the O/W emulsion, based on the total weight of the emulsion, contains [0099] a) 0.1% by weight to 1.0% by weight at least one substance selected from the group of the alkali metal alkyl phosphates, characterized in that the alkyl group has in each case 16 to 18 carbon atoms, wherein the substance is particularly preferably potassium cetyl phosphate, [0100] b) 0.5% by weight to 3.0% by weight hydroxypropyl starch phosphate, and [0101] c) 0.5% by weight to 2.5% by weight sorbitan monostearate,
and the proportion of the oil phase of the emulsion is from more than 5% by weight to 25% by weight.

[0102] It has also been shown, surprisingly, that the temperature stability of the O/W emulsion according to the invention could be increased further by adding one or more fatty alcohols having 14 to 22 carbon atoms to the emulsion. The total proportion of these fatty alcohols having 14 to 22 carbon atoms is advantageously from 0.1% by weight to 5.0% by weight, preferably 0.2% by weight to 4.0% by weight and particularly preferably from 0.5% by weight to 3.0% by weight, based on the total weight of the emulsion.

[0103] Fatty alcohols to be selected with particular preference are cetyl alcohol and/or stearyl alcohol, wherein these are preferably used at proportions from 0.1% by weight to 5.0% by weight, preferably 0.2% by weight to 4.0% by weight and particularly preferably from 0.5% by weight to 3.0% by weight, based on the total weight of the emulsion.

[0104] Advantageous embodiments of the present invention are further characterized in that the O/W emulsion contains further polysaccharide-containing polymers.

[0105] The O/W emulsion of these embodiments advantageously contains tapioca starch, wherein the proportion of tapioca starch is preferably in the range from 0.5% by weight to 3.0% by weight, the weight figures referring to the total weight of the O/W emulsion.

[0106] In addition, the O/W emulsion of these embodiments advantageously contains one or more further starch phosphates, wherein the total proportion of these additional starch phosphates is preferably in the range of 0.5% by weight to 3.0% by weight, where the weight figures refer to the total weight of the O/W emulsion. The term “further starch phosphates” is understood to mean starch phosphates which are different from hydroxypropyl starch.

[0107] In addition, the O/W emulsion of these embodiments advantageously contains xanthan and/or modified xanthan, wherein the total proportion of these polymers is in the range from 0.05% by weight to 0.5% by weight, where the weight figures refer to the total weight of the O/W emulsion.

[0108] In addition, the O/W emulsion of these embodiments advantageously comprises carrageenan, wherein the total proportion of carrageenan is in the range from 0.05% by weight to 0.5% by weight, where the weight figures refer to the total weight of the O/W emulsion.

[0109] Other advantageous embodiments of the present invention are further characterized in that, besides hydroxypropyl starch phosphate, said emulsion contains no other starches and starch derivatives.

[0110] Other advantageous embodiments of the present invention are further characterized in that said emulsion does not contain any celluloses or cellulose derivatives.

[0111] Other advantageous embodiments of the present invention are further characterized in that said emulsion does not contain any further polysaccharide-containing polymers.

[0112] The features of the O/W emulsion according to the invention described below relate to the O/W emulsion according to the invention per se and in each case to the advantageous embodiments according to the invention described above.

[0113] The O/W emulsion according to the invention also advantageously contains one or more lipid components, such as waxes and oils based on hydrocarbons, saturated, unsaturated or hardened triglycerides, dialkyl ethers having 12 to 24 carbon atoms and/or the esters of monohydric alcohols and monocarboxylic acids having at least 10 carbon atoms.

[0114] As already stated, it is advantageous if the O/W emulsion of the present invention contains one or more branched and/or unbranched hydrocarbons, provided these are not gaseous under standard conditions. Hydrocarbons that can be used advantageously are paraffinum liquidum, isododecane, isohexadecane, isoeicosane, squalane and cera microcristallina.

[0115] The O/W emulsion according to the invention advantageously containa one or more triglycerol esters selected from the group of synthetic, semi-synthetic and natural triglycerol esters. Advantageous natural oils containing such natural triglycerol esters are sunflower oil (Helianthus annuus seed oil), rapeseed oil (Canola oil), soybean oil (glycine soya Oil), olive oil (Olea europaea fruit oil), almond oil (Prunus amygdalus dulcis oil), avocado oil (Persea gratissima oil), walnut oil (Junglans regia seed oil), peach kernel oil (Prunus persica kernel oil), apricot kernel oil (Prunus armeniaca kernel oil), sesame oil (Sesamum indicum seed oil), Camelia oil (Camelia oleifera/Camelia sasanqua), evening primrose oil (Oenothera biennis), Macadamia nut oil (Macadamia intergrifolia seed oil), diestel oil (Silybum marianum seed oil), wheat germ oil (Triticum vulgare germ oil), palm kernel oil (Elaeis guineensis kernel oil), palm oil (Elaeis guineensis oil), grape seed oil (Vitis vinifera seed oil), argan oil (Argania spinosa seed oil), peanut oil (Arachis hypogaea oil), pumpkin seed oil (Cucurbita pepo seed oil), castor oil (Ricinus communis seed oil), rice germ oil (Oryza sativa bran oil), vegetable oil (Olus oil) and coconut oil.

[0116] If the O/W emulsion contains one or more of the natural oils mentioned above, the proportion of these natural oils is preferably from 0.01% by weight to 3.0% by weight, based on the total weight of the O/W emulsion.

[0117] Further preferred triglycerol esters include, inter alia, hardened triglyceride fats, such as hydrogenated palm oil, hydrogenated coconut oil or hydrogenated castor oil. Particular preference is given to the use of hydrogenated coconut oil (hydrogenated coco-glycerides), wherein the proportion of hydrogenated coconut oil is preferably from 0.5% by weight to 3% by weight, based on the total weight of the emulsion.

[0118] Furthermore, it is advantageous if the emulsion contains caprylic/capric triglyceride, wherein the proportion of caprylic/capric triglyceride is preferably from 0.5% by weight to 5.0% by weight, based on the total weight of the O/W emulsion.

[0119] Furthermore, it is advantageous in the context of the present invention if the O/W emulsion of the present invention contains one or more dialkyl ethers having 12 to 24 carbon atoms, dicaprylyl ether preferably being present. If the O/W emulsion contains dicaprylyl ether, the proportion of dicaprylyl ether is preferably from 0.5% by weight to 3% by weight, based on the total weight of the O/W emulsion.

[0120] Furthermore, it is advantageous in the context of the present invention if the O/W emulsion of the present invention contains one or more esters of monohydric alcohols and monocarboxylic acids, the esters having at least 10, preferably at least 15 carbon atoms. Esters of monohydric alcohols and monocarboxylic acids to be advantageously selected are 2-ethylhexyl isostearate, isotridecyl isononanoate, 2-ethylhexyl cocoate, C.sub.12-15-alkyl benzoate, isopropyl myristate and isopropyl palmitate.

[0121] It is also advantageous in the context of the present invention if the O/W emulsion contains octyldodecanol.

[0122] It is also preferred in accordance with the invention if the O/W emulsion does not contain any silicone oils. Silicone oils often have the effect that emulsions feel particularly light and absorb rapidly. Surprisingly, it has been found that the emulsion according to the invention is absorbed particularly rapidly after application to skin, even without the presence of silicone oils.

[0123] It is also advantageous according to the invention if the O/W emulsion contains propylene glycol, butylene glycol, 2-methylpropane-1,3-diol, 1,2-pentanediol, 1,2-hexanediol, 1,2-octanediol, or glyceryl caprylate and/or 1,2-decanediol.

[0124] In addition, it is also advantageous in the context of the present invention if the O/W emulsion contains phenoxyethanol, methylparaben, ethylparaben, dehydroacetic acid and/or ethylhexylglycerol.

[0125] If the O/W emulsion contains phenoxyethanol, it is preferred if the proportion of phenoxyethanol is from 0.1% by weight to 1.0% by weight, based on the total weight of the O/W emulsion.

[0126] If the O/W emulsion contains methylparaben and/or ethylparaben, it is preferred if the total proportion of methylparaben and/or ethylparaben is from 0.01% by weight to 0.5% by weight, based on the total weight of the O/W emulsion.

[0127] It is also advantageous if embodiments of the invention are characterized in that these contain ethanol. If ethanol is present in the O/W emulsion, the proportion of ethanol is preferably from 0.5% by weight to 10% by weight, based on the total weight of the O/W emulsion.

[0128] Furthermore, the O/W emulsion according to the invention is preferably characterized in that said emulsion contains glycerol at a proportion of 0.5% by weight to 15% by weight, based on the total weight of the O/W emulsion.

[0129] Furthermore, it is preferred if the O/W emulsion, in addition to the emulsifiers and surfactants according to the invention, only contains further surfactants and/or emulsifiers at a maximum proportion of 2% by weight, preferably at a maximum proportion of 1% by weight and particularly preferably does not contain any further emulsifiers and surfactants, wherein the figures refer to the total weight of the emulsion.

[0130] Last but not least, embodiments advantageous according to the invention are characterized in that the O/W emulsion contains one or more active ingredients selected from the group of the compounds glycyrrhetic acid, urea, arctiin, folic acid, coenzyme Q10 (ubiquinone), alpha-glucosylrutin, carnitine, carnosine, caffeine, natural and/or synthetic isoflavonoids, glycerylglucose, creatine, creatinine, taurine, tocopherol, tocopherol acetate, vitamin C, vitamin C phosphate, vitamin C palmitate, niacinamide, vitamin A palmitate, panthenol, licochalcone A, rucinol, N-[(2,4-dihydroxyphenyl)thiazol-2-yl]isobutyramide, honokiol and magnolol (also as constituent of magnolia extract), hyaluronic acid and/or silymarin (milk thistle extract).

[0131] Furthermore, O/W emulsions advantageous according to the invention are characterized in that said emulsions contains water at a proportion of 60% by weight to 95% by weight and preferably from 70% by weight to 90% by weight, based on the total weight of the emulsion.

[0132] Furthermore, O/W emulsions advantageous according to the invention have a viscosity of 4000 mPas to 10 000 mPas. If viscosity is referred to in this disclosure, all values relate to measurement at 25° C. in a 150 ml snap-lid bottle using a Rheomat R 123 from proRheo. The Rheomat R 123 from proRheo GmbH is a rotational viscometer, i.e. a measurement body rotates in the substance to be measured. The force is measured that is required to rotate the measurement body in the sample at a predefined speed. From this torque, the speed of the measurement body and the geometric dimensions of the measuring system used, the viscosity is calculated. The measurement body used is measurement body No. 1 (article no. 200 0191), speed range 62.5 min.sup.−1. All viscosity measurements are always carried out 24 hours after preparation of the O/W emulsion.

COMPARATIVE EXPERIMENTS AND EXAMPLES

[0133] The examples below are intended to illustrate the present invention without limiting it. Unless otherwise stated, all quantitative data, fractions, and percentages are based on the weight and the total amount or on the total weight of the preparations.

[0134] The following tables list the example formulations Ex. 1 to Ex. 13, in which only the example formulations Ex. 4 to 7 and 10 to 13 disclose O/W emulsions according to the invention. The other example formulations are not in accordance with the invention. Comparison of the O/W emulsions according to the invention and those not according to the invention shows that the O/W emulsions according to the invention do not show any phase separation and are thus significantly more stable at elevated temperatures.

[0135] The O/W emulsions are produced by heating phase A and phase C to 75° C. until all components have dissolved. The phases are then mixed. The mixture is homogenized and then cooled to room temperature with stirring. Phase B is stirred into 60 mL of water (separately from phase A) and, after phase D, is added to the emulsion. The emulsion is then homogenized again.

TABLE-US-00001 Phase Ingredients Ex. 1 Ex. 2 Ex. 3 Ex. 4 A Glycerol 5 5 5 5 Aqua To 100 To 100 To 100 To 100 Sodium cetearyl 0.2 0.2 0.2 0.2 sulfate B Hydroxypropyl — — 2.5 2.5 starch phosphate.sup.1 Tapioca starch — — — — Distarch phosphate — — — — C Cetyl alcohol 2 2 2 2 Hydrogenated coco- 2 2 2 2 glycerides Dicaprylyl ether 3.8 3.8 3.8 3.8 Caprylic/capric 4 4 4 4 triglyceride Glyceryl stearate — 1 — 1 D Phenoxyethanol 0.8 0.8 0.8 0.8 Trisodium EDTA 0.2 0.2 0.2 0.2 Methylparabens 0.3 0.3 0.3 0.3 Storage at 40° C. for 7 days Phase Phase Phase Stable separation separation separation at 50° C. for 7 days Phase Phase Phase Stable separation separation separation Properties when applied to skin No residues, rapid absorption on skin .sup.1commercial product: C*HiForm A 12747 from Cargill

TABLE-US-00002 Phase Ingredients Ex. 5 Ex. 6 Ex. 7 Ex. 8 Ex. 9 A Glycerol 5 5 5 5 5 Aqua To 100 To 100 To 100 To 100 To 100 Sodium cetearyl 1.5 0.2 0.2 0.2 0.2 sulfate B Hydroxypropyl 2.5 5.5 2.5 — — starch phosphate.sup.1 Tapioca starch — — — 2.5 — Distarch phosphate — — — — 2.5 C Cetyl alcohol 2 2 2 2 2 Hydrogenated coco- 2 2 2 2 2 glycerides Dicaprylyl ether 3.8 3.8 3.8 3.8 3.8 Caprylic/capric 4 4 4 4 4 triglyceride Glyceryl stearate 1 1 3.5 1 1 D Phenoxyethanol 0.8 0.8 0.8 0.8 0.8 Trisodium EDTA 0.2 0.2 0.2 0.2 0.2 Methylparabens 0.3 0.3 0.3 0.3 0.3 Storage at 40° C. for 7 days Stable Stable Stable Phase Phase separation separation at 50° C. for 7 days Stable Stable Stable Phase Phase separation separation Properties when applied to skin Distinct Distinct Distinct residues, residues, residues, slow slow slow absorption absorption absorption .sup.1commercial product: C*HiForm A 12747 from Cargill

[0136] In the examples below, the substances listed in the following table are used in each case.

TABLE-US-00003 Substance A Sodium stearoyl glutamate, sodium cetyl stearyl sulfate or potassium cetyl phosphate Substance B Glycerol monostearate or sorbitan monostearate

[0137] This means that if an example preparation comprises the ingredient substance A, this example preparation is shown once with sodium stearoyl glutamate, once with sodium cetyl stearyl sulfate and once with potassium cetyl phosphate. The same applies to substance B.

TABLE-US-00004 Phase Ingredients Ex. 10 Ex. 11 Ex. 12 Ex. 13 A Glycerol 5 5 5 5 Aqua To 100 To 100 To 100 To 100 Substance A 0.2 1.5 0.2 0.2 B Hydroxypropyl 2.5 2.5 5.5 2.5 starch phosphate.sup.1 C Cetyl alcohol 2 2 2 2 Hydrogenated coco- 2 2 2 2 glycerides Dicaprylyl ether 3.8 3.8 3.8 3.8 Caprylic/capric 4 4 4 4 triglyceride Substance B 1 1 1 3.5 D Phenoxyethanol 0.8 0.8 0.8 0.8 Trisodium EDTA 0.2 0.2 0.2 0.2 Methylparabens 0.3 0.3 0.3 0.3 .sup.1commercial product: C*HiForm A 12747 from Cargill

TABLE-US-00005 Example A O/W cream wt % Sodium stearoyl glutamate 0.3 Glycerol monostearate 3 C.sub.12-15 Alkyl benzoate 2 Dicaprylyl ether 2 Octyldodecanol 2 Caprylic acid/capric acid triglycerides 1 Jojoba oil 0.5 Tocopheryl acetate 0.3 Sodium ascorbyl phosphate 0.1 Phenoxyethanol 0.7 Hydroxypropyl starch phosphate 3 Octanediol 0.3 Benzethonium chloride 0.05 Pentylene glycol 2 Glycerol 7 Fillers/additives (TiO.sub.2, BHT) 0.5 Parfum as required Water to 100

TABLE-US-00006 Example B O/W day cream wt % Sodium cetyl stearyl sulfate 0.2 Sorbitan monostearate 2 Cetearyl alcohol 1 C.sub.12-15 Alkyl benzoate 3 Caprylic acid/capric acid triglycerides 2 Dicaprylyl carbonate 2 Octyldodecanol 1 Macadamia oil 0.5 Octocrylene 2 Ethylhexyl methoxycinnamate 3 Octyl salicylate 2 TiO.sub.2 1 Glycyrrhetinic acid 0.1 Folic acid 0.05 Phenoxyethanol 0.8 Octopirox 0.1 Hexanediol 1 EDTA 0.2 Hydroxypropyl starch phosphate 2.5 Glycerol 7 Additives (xanthan gum, BHT) 0.3 Parfum as required Water to 100 pH 7.0

TABLE-US-00007 Example C O/W day cream wt % Sodium stearoyl glutamate 0.3 Sorbitan monostearate 1 Cetearyl alcohol 2 Isopropyl palmitate 3 Ethylhexyl stearate 1 Hydrogenated coconut fatty acid glycerides 1 (Hydrogenated Coco Glycerides) C.sub.12-15 alkyl benzoate 2 Dibutyl adipate 1 Tocophol 0.1 Coenzyme Q10 (ubiquinone) 0.05 Lactic acid sodium salt 0.3 Methylpropanediol 2 Phenoxyethanol 0.5 Benzyl alcohol 0.2 Hydroxypropyl starch phosphate 2 Hyaluronic acid, sodium salt 0.1 NaOH.sub.aq as required Glycerol 8 Additives (EDTA, carrageenan) 0.6 Parfum as required Water to 100 pH 7.0

TABLE-US-00008 Example D O/W cream wt % Sodium cetyl stearyl sulfate 0.3 Sorbitan monostearate 2 Cetyl alcohol 1 C.sub.12-15 Alkyl benzoate 2 Shea butter 0.5 Caprylic acid/capric acid triglycerides 3 Dicaprylyl carbonate 2 Dicaprylyl ether 1 Ethylhexyl cocoate 1 Isohexadecane 1 Citric acid sodium salt as required Phenoxyethanol 0.8 Dipropylene glycol 1 Benzyl alcohol 0.3 Glycyrrhiza inflata extract (licochalcone A) 0.1 Ethylhexylglycerol 0.4 Hydroxypropyl starch phosphate 2 EDTA 0.2 Ethanol 1 Glycerol 5 Additives (EDTA, locust bean gum) 0.6 NaOH.sub.aq as required Parfum as required Water to 100 pH 5.2

TABLE-US-00009 Example E O/W Cream wt % Potassium cetyl phosphate 1 Glyceryl stearate 2 Cetearyl alcohol 1 Caprylic acid/capric acid triglycerides 2 C.sub.12-15 Alkyl benzoate 2 Sunflower oil 0.5 Coconut glycerides 2 Octyldodecanol 1 Triisostearin 1 Cetearyl isononanoate 1 Methyl p-hydroxybenzoate (paraben) 0.2 Hydroxypropyl starch phosphate 1.5 Octanediol 0.2 4-hydroxyacetophenone 0.2 Glycerol 5 Panthenol 1 Additives (hydroxypropylmethylcellulose, BHT) 0.5 Parfum as required Water to 100